03737 ZHONGZHIPHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.60X | Oper Margin | 1.4% |
|---|---|---|---|
| LT Debt/Equity | 7.9% | Net Margin | 1.0% |
| Total Debt/Equity | 11.9% | Return on Equity | 1.6% |
| Price/Book | 0.57X | Return on Assets | 0.9% |
| (HKD 0.800) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 19.25 | 101.26 | 179.41 | 119.28 | 63.76 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -81.0 | -43.6 | +50.4 | +87.1 | -61.2 |
| Earnings Per Share (HKD) | 0.023 | 0.12 | 0.212 | 0.141 | 0.076 |
| Earnings Per Share Growth (%) | -80.5 | -43.4 | +50.4 | +84.8 | -61.6 |
| Dividend Per Share (HKD) | No dividend | 0.050 | 0.090 | 0.090 | No dividend |
| P/E* (X) | 34.19 | 6.68 | 3.78 | 5.68 | 10.50 |
| Yield (%) | N/A | 6.25 | 11.25 | 11.25 | N/A |
| Dividend Share (%) | N/A | 41.74 | 42.49 | 63.92 | N/A |
| Book NAV (HKD) | 1.411 | 1.375 | 1.338 | 1.302 | 1.273 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,737 | 2,215 | -21.6 | 2,050 |
| Operating Result | 18.987 | 146.349 | -87.0 | 207.15 |
| Profit Before Taxation | 18.987 | 146.897 | -87.1 | 207.581 |
| Taxation | 1.285 | 50.75 | -97.5 | 43.447 |
| Profit /( Loss) After Taxation | 17.702 | 96.147 | -81.6 | 164.134 |
| Minority Interests | 0.412 | 0.935 | -55.9 | 1.359 |
| Net Profit | 17.29 | 95.212 | -81.8 | 162.775 |
| Earnings Per Share () | 0.0234 | 0.1198 | -80.5 | 0.2118 |
| Dividend Per Share () | 0.0000 | 0.0500 | -100.0 | 0.0900 |
| Announcement Date | 2026-03-26 | 2025-03-26 | NA | 2024-03-22 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
